Recommendations for prioritizing subgroups of patients younger than 65 for vaccination against SARS-CoV-2 (phase Ib)
In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council highlights the priorities for vaccinating at-risk patients against COVID-19 (Phase Ib). This report aims at providing the Belgian Immunization Strategy and Operationalization Taskforce and general practitioners with specific recommendations on strategic COVID-19 vaccination in Belgium.
(For now, only available in Dutch or French.)
Report 9618 - Appendix 2 - Anaphylaxis: Recommendations for prioritization at-risk groups for SARS-CoV-2 Vaccination (Phase 1b)
Néerlandais20210412_hgr-9618_priorites_vaccination_covid-19_vweb.pdf PDF document - 3.95 Mo